Our Mission

Our mission is to establish new equilibriums that solve complex diseases.

As a clinical-stage company focused on macrophage reprogramming, we intend to develop and commercialize a drug pipeline for macrophage reprogramming in solid cancers, Sepsis, COVID-19 and other indications.

Our pioneering Allocetra™ cell-based therapy breaks with old paradigms, offering to effectively treat numerous acute conditions through a radically different clinical approach.

Advanced clinical-stage pipeline

Advanced clinical-stage pipeline

Short regulatory approval pathway

Short regulatory approval pathway
FDA & EU orphan designations; Specialized Life-Threatening Regulation in Europe potentially enables post-Phase II marketing approval

Multi-billion-dollar markets

Multi-billion-dollar markets
Solid cancers, sepsis, COVID-19

Take a look at our company overview

Download

Strong leadership,
inspired by great science and a sense of mission

Our management, clinical advisors, personnel, and affiliates have extensive knowledge
in the research and development of therapies based on macrophage reprogramming.

  • Shai Novik

    Executive Chairman

    Open Modal

    Oren Hershkovitz, Ph.D.

    Chief Executive Officer

    Open Modal

    Prof. Dror Mevorach, M.D.

    Chief Scientific & Medical Officer

    Open Modal

    Odelia Ben-Shitrit

    Head of Clinical Operations

    Open Modal

    Danny Fishelovitch, Ph.D.

    Head Of CMC

    Open Modal

    Shachar Shlosberger

    CFO

    Open Modal
  • Dr. Brian Schwartz, MD

    Director

    Open Modal

    Sangwoo Lee

    Director

    Open Modal

    Abraham Havron, Ph.D

    Director

    Open Modal

    Bernhard Kirschbaum, Ph.D

    Director

    Open Modal

    Michel Habib

    Director

    Open Modal

    Gili Hart, Ph.D

    Director

    Open Modal

    Baruch Halpert

    Director

    Open Modal
  • Dr. Paul J. Martin, MD

    Fred Hutchinson Cancer Research Center, University of Washington

    Open Modal

    Dr. Mohamad Mohty, MD, PHD

    Saint-Antoine Hospital, Paris

    Open Modal

    Dr. James Ferrara, MD

    The Icahn School of Medicine at Mount Sinai

    Open Modal

    Dr. Mitchell Levy, MD, MCCM

    The Warren Alpert Medical School of Brown University

    Open Modal

    Dr. Clifford Deutschman, MD

    The Feinstein Institute for Medical Research

    Open Modal